Bioengineering Technology Research Report 2025-2034 CRISPR And AI Drive Innovations In Health And Agriculture, Sustainable Practices And Personalized Medicine Accelerate Expansion

(MENAFN- GlobeNewsWire - Nasdaq) The Global Bioengineering Technology Market, valued at USD 294.5 billion in 2025, is projected to grow at a CAGR of 12.3%, reaching USD 835.4 billion by 2034. This market is driven by advancements in CRISPR-Cas9, bioprinting, and AI integration, supporting personalized medicine and sustainable practices. North America and Europe lead, with Asia-Pacific emerging rapidly. Key drivers include demand for personalized medicine and sustainable agriculture, while challenges involve high costs and regulatory concerns.

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Bioengineering Technology Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" report has been added to ResearchAndMarkets.com's offering.
Global Bioengineering Technology Market is valued at USD 294.5 billion in 2025. Further, the market is expected to grow at a CAGR of 12.3% to reach USD 835.4 billion by 2034.

The bioengineering technology market encompasses a diverse range of innovations aimed at advancing healthcare, agriculture, environmental sustainability, and industrial processes. Bioengineering integrates biological principles with engineering techniques to develop cutting-edge solutions such as tissue engineering, synthetic biology, bioprocessing, and genetic engineering.
These technologies are instrumental in producing biopharmaceuticals, improving agricultural productivity, addressing environmental challenges, and enhancing the production of bio-based materials and energy sources. The market's rapid growth is driven by increasing demand for personalized medicine, sustainable agricultural practices, and environmentally friendly production processes.
Technological advancements and interdisciplinary collaborations are propelling the market forward. The rise of CRISPR-Cas9 and other gene-editing tools has revolutionized genetic engineering, enabling precise modifications to organisms for therapeutic and industrial applications. Meanwhile, advancements in bioprinting and tissue scaffolding are opening new possibilities in regenerative medicine, organ transplantation, and drug discovery. Moreover, the convergence of bioengineering with data analytics, artificial intelligence, and high-throughput screening technologies has accelerated the pace of innovation, leading to more efficient workflows and faster product development timelines.
Regionally, North America and Europe lead the bioengineering technology market, supported by strong research funding, well-established biotechnology industries, and favorable regulatory environments. Asia-Pacific is emerging as a fast-growing region due to increasing investment in biotechnology research, expanding healthcare infrastructure, and rising demand for agricultural and industrial bioengineering solutions. As global challenges such as climate change, food security, and public health continue to intensify, bioengineering technology is positioned to play a pivotal role in delivering sustainable, scalable, and impactful solutions across multiple sectors.

What You Receive

• Global Bioengineering Technology market size and growth projections (CAGR), 2024- 2034
• Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Bioengineering Technology.
• Bioengineering Technology market size, share, and outlook across 5 regions and 27 countries, 2025- 2034.
• Bioengineering Technology market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025- 2034.
• Short and long-term Bioengineering Technology market trends, drivers, restraints, and opportunities.
• Porter's Five Forces analysis, Technological developments in the Bioengineering Technology market, Bioengineering Technology supply chain analysis.
• Bioengineering Technology trade analysis, Bioengineering Technology market price analysis, Bioengineering Technology Value Chain Analysis.
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products.
• Latest Bioengineering Technology market news and developments.

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2025 - 2034
Estimated Market Value (USD) in 2025	$294.5 Billion
Forecasted Market Value (USD) by 2034	$835.4 Billion
Compound Annual Growth Rate	12.3%
Regions Covered	Global

Trends

• Rapid advancements in gene-editing technologies, particularly CRISPR, driving innovation in healthcare and agriculture.
• Integration of bioengineering with AI and data analytics for accelerated research and product development.
• Expansion of bio-based materials and biofuels to address environmental sustainability and reduce dependence on fossil resources.

Drivers

• Growing demand for personalized medicine and advanced therapeutic solutions.
• Increasing emphasis on sustainable agricultural practices and bio-based industrial processes.
• Strong investments from governments, research institutions, and private companies in bioengineering R&D.

Challenges

• High costs and technical complexities associated with developing and scaling bioengineering technologies.
• Regulatory and ethical considerations, particularly around genetic modifications and synthetic biology.
• Limited infrastructure and expertise in certain regions, slowing the adoption of advanced bioengineering applications.

Companies Featured

• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Novartis AG
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific
• Abbott Laboratories
• AstraZeneca plc
• Medtronic plc
• Gilead Sciences Inc.
• Amgen Inc.
• Novo Nordisk A/S
• Moderna Inc.
• Becton Dickinson (BD)
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Agilent Technologies
• Lonza Group Ltd.
• Intuitive Surgical
• Illumina Inc
• Bio-Rad Laboratories
• Ginkgo Bioworks
• Verve Therapeutics Inc.
• CRISPR Therapeutics

Market Segmentation

By Product

• Biomedical Engineering
• Genetic Engineering
• Biotechnology
• Tissue Engineering
• Biomechanics Engineering
• Biomaterial
• Biomechanical Engineering
• Nano-biotechnology
• Bioinformatics
• Other Products

By Technology

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation

By Application

• Health
• Food And Agriculture
• Natural Resources And Environment

By Geography

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Bioengineering Technology Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN30062025004107003653ID1109740509